跳至主要内容
临床试验/NCT03985462
NCT03985462撤回1 期

Autologous Very Small Embryonic-like Stem Cells(VSELs) for Premature Ovarian Failure

Fuda Cancer Hospital, Guangzhou1 个研究点 分布在 1 个国家开始时间: 2019年7月3日最近更新:
适应症

试验速览

阶段
1 期
状态
撤回
发起方
试验地点
1
主要终点
Concentration of Blood female hormones level

研究概览

简要总结

The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to premature ovarian failure.

详细描述

Premature ovarian failure is diagnosed by blood femal hormones test of follicle stimulating hormone (FSH, > 40 IU/L)、luteinizing hormon (LH, > 40 IU/L)、estradiol (E2, > 100pg/mL) and/or amenorrhea before the age of 40. VSELs come from the patient's periperal blood, and will be injected in bilateral oviducts, followed-up by hormone testing and menstrual conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

盲法说明

The number of patients enrolled and the number of injected cells were randomly selected by the investigator

入排标准

年龄范围
30 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients who are diagnosed as premature ovarian failure by professional doctor.
  • Those have clear abnormal sex hormone levels

排除标准

  • Unmarried woman
  • Suffering from other serious gynecological diseases or gynecological tumors
  • Blood disease patients, thrombocytopenia or dysfunction, hypofibrinemia or anticoagulant therapy, long-term use of aspirin

结局指标

主要结局

Concentration of Blood female hormones level

时间窗: 1 month after injection

Check whether blood FSH, LH and E2 levels return to normal

次要结局

  • Incidence of amenorrhea(12 months after injection)
  • Concentration of Blood female hormones level(12 months after injection)

研究者

发起方
Fuda Cancer Hospital, Guangzhou
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验